RHO rs121918353: Understanding the P23H Variant
The rs121918353 variant in the RHO gene, commonly known as the P23H mutation, is a well-documented genetic change linked to autosomal dominant retinitis pigmentosa. This variant affects the production of rhodopsin, a protein essential for vision in low-light conditions.
What each genotype means
Typical rhodopsin function
This genotype represents the common, wild-type sequence for the RHO gene at this position. Individuals with this genotype do not carry the specific p.Pro23His mutation associated with autosomal dominant retinitis pigmentosa.
This is the most common genotype found in the global population.
Increased risk of retinitis pigmentosa
This genotype includes the p.Pro23His mutation, which is a well-documented cause of autosomal dominant retinitis pigmentosa. This variant impairs the proper folding and trafficking of the rhodopsin protein in the retina, which can lead to progressive vision loss starting with night blindness. Please consult with an ophthalmologist or a genetic counselor to discuss clinical implications and appropriate eye health monitoring.
This genotype is very rare, with a global minor allele frequency of less than 0.00005, though it is a recurrent pathogenic finding in North American and European cohorts.
High risk of retinitis pigmentosa
This genotype indicates the presence of the p.Pro23His mutation on both copies of the RHO gene. Because this condition is typically inherited in an autosomal dominant manner, carrying this variant is strongly associated with the development of retinitis pigmentosa. You should discuss these results with a medical professional or genetic specialist to understand your specific health risks and management options.
This genotype is extremely rare and is not typically observed in general population databases.
What is the rs121918353 Variant?
The variant rs121918353, frequently referred to in scientific literature as the P23H mutation, is a specific change in the DNA sequence of the RHO gene. In this variant, a single nucleotide substitution leads to an amino acid change where proline is replaced by histidine at position 23 of the rhodopsin protein. This specific site is located within the N-terminal region of the protein, which is critical for its proper folding and function. Because this change occurs in a single copy of the gene, it is classified as an autosomal dominant trait, meaning that inheriting the variant from one parent is sufficient to influence the associated condition. This variant has been extensively studied as a landmark example of how a single-base change can disrupt the complex biological machinery of the eye.
The Role of the RHO Gene
The RHO gene provides the instructions for creating the rhodopsin protein, which is found in the rod photoreceptor cells of the retina. Rod cells are specialized light-sensitive cells located at the back of the eye that allow us to see in low-light environments, such as at night. Rhodopsin acts as a light-sensitive pigment that captures photons and initiates the chemical signals sent to the brain to create visual images. When the RHO gene functions normally, rhodopsin is correctly folded and transported to the outer segments of the rod cells. However, when the P23H variant is present, the resulting rhodopsin protein often misfolds. This misfolding can cause the protein to be retained within the endoplasmic reticulum of the cell, triggering cellular stress responses that may eventually lead to the dysfunction or death of the rod photoreceptor cells.
Research and Clinical Associations
Research has consistently associated the rs121918353 variant with autosomal dominant retinitis pigmentosa (adRP), a condition characterized by the progressive loss of vision. The evidence for this association is strong, as the P23H mutation was one of the first identified genetic causes of retinitis pigmentosa. Studies have shown that the misfolded protein creates an 'endoplasmic reticulum overload,' which activates the unfolded protein response and leads to apoptosis, or programmed cell death, of the photoreceptors. While this variant is a well-known cause of adRP, the severity and progression of vision loss can vary between individuals. Current research is actively exploring therapeutic avenues, including gene editing and gene delivery techniques, to potentially rescue photoreceptor function in models carrying this specific mutation. It remains a primary focus for understanding the mechanisms of inherited retinal degeneration.
What You Can Do With This Information
If you or a family member have been identified as a carrier of the rs121918353 variant, it is important to understand that this information is for educational purposes and does not constitute a medical diagnosis. Genetic testing results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or an ophthalmologist specializing in retinal diseases. They can provide context regarding your specific health history and discuss the implications for family planning or potential clinical monitoring. Because this variant is associated with progressive vision loss, regular eye examinations are often recommended to monitor retinal health. Please note that there is no single 'treatment' for the variant itself; any management strategies or potential clinical trial participation must be discussed directly with your medical team. Never make changes to your health management based solely on genetic data without professional guidance.
How common is this variant?
The rs121918353 variant is very rare, with a global minor allele frequency (MAF) of less than 0.00005 in the gnomAD database. It is recognized as a recurrent pathogenic allele primarily identified in North American and European cohorts.
Frequently asked questions
What is the P23H mutation?
The P23H mutation is a specific genetic change in the RHO gene where the amino acid proline is replaced by histidine at position 23. This change causes the rhodopsin protein to misfold, which is a known cause of autosomal dominant retinitis pigmentosa.
Is retinitis pigmentosa curable?
Currently, there is no cure for retinitis pigmentosa. Research is ongoing into gene therapies and other treatments to slow the progression of vision loss, but these are generally in experimental or clinical trial stages.
How is the RHO variant inherited?
The RHO variant associated with retinitis pigmentosa is inherited in an autosomal dominant pattern. This means that an individual only needs to inherit one copy of the mutated gene from one parent to be at risk for the condition.
Should I get tested for the RHO gene?
Genetic testing for the RHO gene is typically recommended by ophthalmologists or genetic counselors if there is a family history of retinal disease or if a patient is experiencing symptoms of vision loss. You should discuss the necessity and implications of such testing with your healthcare provider.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121918353?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in RHO
Pathogenic missense variant causing rhodopsin Pro23His substitution that leads to autosomal dominant retinitis pigmentosa and progressive night blindness.
Constitutively active rhodopsin variant (Gly90Asp) causing autosomal dominant congenital stationary night blindness (CSNB).
Encodes the Pro23His (P23H) substitution in rhodopsin, the most common autosomal dominant retinitis pigmentosa allele in North America.
A non-synonymous variant altering rhodopsin protein structure that causes autosomal dominant retinitis pigmentosa with progressive rod photoreceptor loss.
Rhodopsin missense variant (p.Pro23His) responsible for classical autosomal dominant retinitis pigmentosa with rod photoreceptor degeneration.
Classic Pro23His (p.P23H) mutation in rhodopsin causing autosomal dominant retinitis pigmentosa.